Case studies
Working with our customers to reduce time to market, deliver on quality, provide deep therapeutic expertise, and enhance R&D ROI.
Highlights
We focus our innovation on the factors that matter most — accelerating time to market, reducing costs and enhancing quality. Learn more about how we've helped clients meet and exceed their goals in this selected library of case studies.
Proactive patient retention strategy in a GLP-1 RA trial
Explore how ICON successfully supported a sponsor’s cardiovascular outcome trial for a GLP-1 receptor agonist with 9,900+ patients with type 2 diabetes and maintained a retention rate of 97% over 7 years.
A small biotech success story
A small US-based biotech company was in a race to be the first to market with their lead targeted oncology product.
FSP partnership - sustained efficiency and ongoing innovation
The implementation of an FSP model across our partner's project management function, led to 20% cost efficiences and a 30% reduction in client burden.
By taking a site and patient-centric approach, and leveraging advanced tools and real-time data insights, we maximise patient access, recruitment, and retention—ensuring that every trial is conducted with efficiency, agility, and a commitment to improving patient outcomes.
All case studies
Select amongst our broad range of solutions and experience.
Achieving highly accurate social media measurement
Symphony Health partnered with a social media company to develop a privacy-compliant ad measurement solution for a pharma client. Using machine learning, they maintained 90% accuracy while meeting stricter privacy standards—offering a scalable model for regulated environments.
Quantifying the impact of SDOH
Understanding Social Determinants of Health (SDOH) is key to addressing disparities and improving outcomes in Type 2 Diabetes. While factors like diet and access to care are known, quantifying their impact on diagnosis, treatment initiation, and adherence remains an emerging focus.
Using RWE to differentiate TYK2 inhibitors in a crowded psoriasis market
A pharma company partnered with Symphony Health to guide the launch of a TYK2 inhibitor for psoriasis. They explored market potential, free drug programs, treatment patterns, and prescribing behavior—especially among NPs and PAs—to shape positioning in a competitive landscape.
Disparities in access to branded migraine therapies
CGRP inhibitors have expanded migraine treatment, but payer barriers often limit access, especially for vulnerable groups. A patient advocacy client worked with Symphony Health to explore disparities in access and their impact on outcomes like ER visits and hospitalizations.
Leveraging Real-World Data and machine learning
Early cancer detection is vital, yet many cases—especially lung cancer—are diagnosed late, limiting treatment options. Life sciences organizations now use real-world data and machine learning to identify subtle, pre-diagnostic signals in patient journeys, enabling earlier intervention and improved outcomes.
Line of therapy analysis to support commercialisation efforts of rare disease
Pulmonary arterial hypertension (PAH) often presents with vague symptoms, making diagnosis difficult and leading to frequent delays or misdiagnoses. While current treatments have improved outcomes, underserved populations with limited access to specialized care remain under treated.
Accelerating team growth to support client demand
This case study shows the effectiveness of this agile and forward-thinking approach to workforce scaling under time-
sensitive conditions.
sensitive conditions.
Privacy-safe, high-performing digital campaign targeting
Symphony Health, an ICON plc company, and a trusted provider of healthcare data and analytics, collaborated with
Butler/Till to enhance the digital media buying strategy for a major pharmaceutical company.
Butler/Till to enhance the digital media buying strategy for a major pharmaceutical company.
Driving better outcomes with innovative interventions
A major pharmaceutical client explored whether a wellness app for glucose monitoring and nutrition coaching could reduce A1c levels in Type 2 Diabetes patients. They also assessed its potential to lower healthcare costs and its commercial viability for payer-supported integration into treatment plans.
Breakthrough patient reach
In Q1 2024, Underscore Marketing launched an innovative unbranded campaign to educate patients with a rare lung disease. Using advanced data and privacy-compliant methods, the initiative validated symptoms and introduced a soon-to-be FDA-approved treatment, setting a new benchmark for disease education in healthcare.
Symphony Health and dentsu health partner to reach rare disease patients
As a part of their ongoing Test & Learn strategy, dentsu health collaborated with several data partners to assess healthcare claims models and measure Audience Quality across two direct-to-consumer (DTC) display campaigns.
Scaling an optimised global vaccine trial with flexible FSP
ICON partnered with a leading pharma company to scale its global vaccine program using flexible, custom FSP solutions. By combining dedicated teams with on-demand support, ICON helped expand trial reach, adapt to changing needs, and deliver nearly $10M in annual cost savings.
Let's collaborate
Discover how ICON's expertise transforms clinical trials.